TPA Could Help Stroke Victims Survive
June 12, 2009
The clot-busting drug TPA needs to be administered to stroke patients within three hours of their first symptom, but new research indicates that window can be extended in some cases.
Topics:
Health Medical Pharma, Hematology, Aging-associated diseases, stroke, Tissue plasminogen activator, Thrombolysis, Thrombus
